If your patients are suffering from depression, medication trials can be frustrating and leave patients feeling worse. By analyzing clinically important genetic variations that may affect your patient’s response to psychiatric medications, the GeneSight® Psychotropic test provides information that can help guide your medication selection.
Please let us know how we can help by filling out the form below.
Take the Next Step - PD
Largest Depression Pharmacogenomic Clinical Study Ever Demonstrates GeneSight Psychotropic Test Efficacy
as Published in the Journal of Psychiatric Research
Collect a DNA sample by painlessly swabbing the inside of your patient’s cheek.
The sample is sent to our lab for analysis.
In about 36 hours, your patient’s report is available for review.
Guided by insights from your patient’s report, you can inform on medication selection.
See what happens when the GeneSight® test becomes part of a clinician’s practice.